NXTS logo

NEXENTIS TECHNOLOGIES INC

NXTSNASDAQ
🏆 #5372 by market capEarnings Dec 2US Equity
——
Quote unavailable
🔔
Track NXTS
Get earnings, price moves & breaking news on Telegram
Track
24h—
7d—
14d—
30d—
ytd—
1y—
🏦Market Cap
$32,825
Small Cap
📈Revenue Growth (YoY)
-100.0%
Declining
📊Gross Margin
263.6%
High
💵FCF Margin
7069.9%
Strong
⚖️P/S Ratio
-0.5x
Cheap
Otter Score
—
Insufficient data
No chart data available for NXTS.

Trading Snapshot

Day Range
—
52-Week Range
$0.50 – $25.83
Volume (shares)
—
Avg Volume (shares)
—
Shares Outstanding
56,594
Next Earnings
2026-12-02

Fundamentals Snapshot

Annual Revenue
—
Last Q Revenue
—
P/E Ratio
-0.0
P/S Ratio
-0.5x
EPS (TTM)
$-19.64
Dividend Yield
0.00%
Dilution (1yr)
+14.5%
NXTS logo

NEXENTIS TECHNOLOGIES INC

NXTS
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$0▼ −100.0% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
15.7%▼ −77.9% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
−$4M▲ +4.5% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
−$4M▲ +11.8% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
394K▲ +14.5% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$3M▲ +$638K YoY
StockOtter · stockotter.space

About NEXENTIS TECHNOLOGIES INC

Nexentis Technologies Inc., through its subsidiary, develops therapeutics related to cancer and inflammatory metabolic diseases. It operates through two segments, Biotechnology Activity and Renewable Energy Projects. The company's pipeline includes MITOLINE, an algorithm used to perform multiple sequence/ structure pairwise alignments which could then be used for generating a 3D comparative model of potentially all mitochondrial carrier proteins; cloud-based computational chemistry platform; and novel in-vitro screening platforms; and advanced 3D NSCLC tumor spheroid systems.The company was formerly known as N2OFF, Inc. and changed its name to Nexentis Technologies Inc. in February 2026. Nexentis Technologies Inc. was incorporated in 2009 and is headquartered in Ness Ziona, Israel.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)

Insufficient data for all five components.

💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
💧Dilution★★★★★
Overall Score
Insufficient data
—/100
Analyst data unavailable.

Latest News & Updates

News unavailable.